Avoid Valeant (VRX) Stock?

Valeant Pharmaceuticals International (VRX 37.00) has garnered a lot of news lately. Valeant's stock continues to rise after the company won approval from loan holders to amend terms of the company’s debt, granting the pharmaceutical company an additional month to file its annual report.
Read More